Rituximab monotherapy become an optimal treatment for primary pulmonary malt lymphoma

Publication date: 2018Source: Leukemia Research Reports, Volume 9Author(s): A.I. Alvarez-Sánchez, C. Martínez-Losada
Source: Leukemia Research Reports - Category: Hematology Source Type: research
More News: Leukemia | Lymphoma | Rituxan